Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product LineAccesswire • 05/19/22
Zomedica CEO Interview with Wall Street Analyzer Discusses First Quarter 2022 Earnings and Future PlansAccesswire • 05/16/22
Zomedica Announces First Quarter 2022 Revenues of $3.8 Million; 74% Gross Margin & $192.3 Million in Cash; Revenue up 38% from 2021 Combined RevenuesAccesswire • 05/10/22
Zomedica(R) Supports Feline Animal Health With American Association of Feline Practitioners' SponsorshipAccesswire • 05/04/22
Zomedica's Announces Designation of Pulsevet System as the Official Shock Wave Therapy of the American Quarter Horse AssociationAccesswire • 04/13/22
Zomedica Announces Fourth Quarter and 2021 Revenues of $4.1 Million; 73.9% Gross MarginAccesswire • 02/25/22